^
Association details:
Biomarker:No biomarker
Cancer:Neuroendocrine Tumor
Drug:cisplatin (DNA synthesis inhibitor) +
etoposide IV (Topoisomerase II inhibitor)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Bronchopulmonary/Thymus Neuroendocrine Tumors...Useful in Certain Circumstances...Poorly Differentiated Neuroendocrine Carcinoma/Large or Small Cell (Extrapulmonary):...Cisplatin + etoposide.